Abstract
Purpose
Fatty acid synthase is a common phenotype to various human cancers including those of prostate, colon, lung, endometrium, and stomach. Increased fatty acid synthase levels have been detected in serum from patients with breast and pancreatic cancer. In this study, serum levels of fatty acid synthase were measured in colorectal cancer patients at different stages of disease.
Methods
Consecutive 67 patients with colorectal cancer were enrolled in the study. Serum levels of fatty acid synthase were examined by ELISA test. The Kruskal–Wallis test and the χ 2 method for trend have been used to analyze data.
Results
Serum fatty acid synthase levels of patients belonging to three groups of stage disease are statistically different. The patients with stage III and IV have significantly higher serum levels of fatty acid synthase than patients with stage I–II. There is a positive trend in serum fatty acid synthase levels from stage I–II to stage III and IV of disease.
Conclusions
Fatty acid synthase levels are associated with the stage of disease in patients with colorectal cancer.
This is a preview of subscription content, log in via an institution to check access.
References
Mashima T, Seimiya H, Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer. 2009;100:1369–72.
Kuhajda FP. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 2006;66:5977–80.
Ogino S, Nosho K, Meyerhardt JA, et al. Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol. 2008;26(35):5713–20.
Notarnicola M, Altomare DF, Calvani M, et al. Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex. Oncology. 2006;71(5–6):327–32.
Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7:763–77.
Wang Y, Kuhajda FP, Li JN, et al. Fatty acid synthase expression in human breast cancer cell culture supernatants and in breast cancer patients. Cancer Lett. 2001;167:99–104.
Walter K, Hong S-M, Nyhan S, et al. Serum fatty acid synthase as a marker of pancreatic neoplasia. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2380–5.
Vazquez-Martin A, Fernandez-Real JM, Oliveras-Ferraros C, et al. Fatty acid synthase activity regulates HER2 extracellular domain shedding into the circulation of HER2-positive metastatic breast cancer patients. Int J Oncology. 2009;35:1369–76.
Milgraum LZ, Witters LA, Pasternack GR, et al. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res. 1997;3:2115–20.
Swinnen JV, Roskams T, Joniau S, et al. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer. 2002;98:19–22.
Piyathilake CJ, Frost AR, Manne U, et al. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol. 2000;31:1068–73.
Kuhajda FP. Fatty acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 2000;16:202–8.
Wang Y, Kuhajda FP, Li J, et al. Fatty acid synthase as a tumor marker: its extracellular expression in human breast cancer. J Exp Ther Oncol. 2004;4:101–10.
Conflict of Interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Notarnicola, M., Tutino, V., Calvani, M. et al. Serum Levels of Fatty Acid Synthase in Colorectal Cancer Patients Are Associated with Tumor Stage. J Gastrointest Canc 43, 508–511 (2012). https://doi.org/10.1007/s12029-011-9300-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-011-9300-2